• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Gaxos Announces Strategic AI Tech Acquisition to Expand Content Creation Capabilities

    3/5/25 7:30:00 AM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology
    Get the next $GXAI alert in real time by email

    Roseland, NJ, March 05, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that the Company has acquired AI technology to bolster its content creation services. This acquisition immediately expands the capabilities of Gaxos Labs and enhances the Company's broader AI development initiatives, setting the stage for growth.

    This strategic addition equips Gaxos with AI solutions, including advanced text-to-speech (TTS), high-quality image generation, dynamic video assembly, instant narration, enhanced styling, and script automation, unlocking unprecedented possibilities for both users and enterprises.

    "This acquisition immediately strengthens our AI ecosystem," said Vadim Mats, CEO of Gaxos.AI. "By integrating this technology, we are supercharging our product capabilities and accelerating the future of AI-powered content creation."

    For more information, visit Gaxos Labs where you'll find more information on Gaxos Labs and all it offers game developers and players. You can also follow Gaxos Labs on X, Facebook, or Gaxos.ai on LinkedIn for the latest updates and news. 

    About Gaxos.ai Inc.

    Gaxos.AI isn't just developing applications; it's redefining the human-AI relationship. Our offerings span health and wellness as well as gaming. We're committed to addressing health, longevity, and entertainment, through AI solutions.

    Forward-Looking Statements

    All statements other than statements of historical fact in this announcement are forward-looking statements that involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. Investors can identify these forward-looking statements by words or phrases such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's filings with the SEC.

    Gaxos.ai Inc. Company Contact

    Investor Relations

    E:[email protected]

    T: 1-888-319-2499



    Primary Logo

    Get the next $GXAI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GXAI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $GXAI
    SEC Filings

    View All

    Gaxos.ai Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - GAXOS.AI INC. (0001895618) (Filer)

    2/4/26 5:14:56 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    SEC Form 424B5 filed by Gaxos.ai Inc.

    424B5 - GAXOS.AI INC. (0001895618) (Filer)

    2/4/26 5:11:57 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    SEC Form 424B5 filed by Gaxos.ai Inc.

    424B5 - GAXOS.AI INC. (0001895618) (Filer)

    1/23/26 4:35:48 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    $GXAI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AI, Advanced Materials and Enterprise Security Drive Small-Cap Momentum

    DENVER, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Execution is the theme this morning, as a cluster of emerging growth names move from pilot programs and strategic roadmaps into operational scale. Kraig Biocraft Laboratories Moves from Plan to Production Kraig Biocraft Laboratories (OTCQB:KBLB) announced that its 2026 production strategy has officially shifted into execution mode, with bio-material moved into incubation ahead of its March production run. The company is targeting sustained monthly 10 metric-ton-level output of recombinant spider silk cocoons, an ambitious scale-up initiative in a niche but potentially transformative advanced materials market. CEO Kim Thompson characterized the d

    2/17/26 10:11:28 AM ET
    $GXAI
    $OBAI
    $RIME
    Computer Software: Prepackaged Software
    Technology
    Telecommunications Equipment
    Consumer Discretionary

    Gaxos Inks Deal with BytePlus, Enterprise Technology Division of Bytedance

    Preferred model pricing and cutting-edge AI accelerate Art-Gen growth and global creator adoption Roseland, NJ, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various high-growth sectors, today announced that it finalized a deal with Byteplus, the Enterprise Technology Division of ByteDance. Under the agreement, Gaxos will receive preferred pricing and significant discounts on ByteDance's cutting-edge video generation models, enabling faster deployment of AI capabilities inside Art-Gen, Gaxos' flagship AI image and video creation platform that makes pro-grade content effortless for anyone, anywh

    2/17/26 8:12:00 AM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    Amazon AWS Funds Gaxos AI Sales Platform Development

    Caylent Named Development Partner to Lead AWS-Native Build Roseland, NJ, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various high-growth sectors, today announced that Amazon Web Services ("AWS") has committed to fund the preliminary development of Gaxos Labs' innovative, AI-powered sales coaching platform, positioning Gaxos to compete in the multibillion- dollar sales technology market. The AWS-backed initiative, in collaboration with Caylent, an AWS premier partner, supports the development of a real-time, AI sales platform designed for enterprise-scale deployment, incorporating live call t

    2/3/26 8:12:00 AM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    $GXAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Holzer Adam

    4 - GAXOS.AI INC. (0001895618) (Issuer)

    4/15/25 7:03:36 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Director Grayson Scott

    4 - GAXOS.AI INC. (0001895618) (Issuer)

    4/15/25 7:02:46 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Director Feldman Roman

    4 - GAXOS.AI INC. (0001895618) (Issuer)

    4/15/25 7:01:32 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    $GXAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Gaxos.ai Inc.

    SC 13G - GAXOS.AI INC. (0001895618) (Subject)

    11/14/24 3:30:50 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    $GXAI
    Financials

    Live finance-specific insights

    View All

    Gaxos Acquires Rights to AI-enabled Technology from Top Biohacking App

    Roseland, NJ, March 13, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it had acquired the rights to use certain AI-enabled technology from a top biohacking app, "Ultiself," in order to facilitate the development of its tech for Gaxos Health. The integration of Ultiself's proprietary technology into Gaxos Health's proposed product offering will enable enhanced customization and user experience aligning with modern-day consumer's demands for custom and efficient solutions. This move is expected to accelerate Gaxos Health's development and help solidify its positio

    3/13/24 8:30:00 AM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    $GXAI
    Leadership Updates

    Live Leadership Updates

    View All

    Gaxos Health Expands Medical Advisory Board

    Roseland, NJ, April 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell. "The addition of top medical talent to our Medical Advisory Board reflects our continued commitment to pursuing a best-in-class solution for Gaxos Health," said Vadim Mats, CEO of Gaxos.AI. "An advisory board of experts in their respective fields will allow to create a better product and advancing our mission of creating value for shareholders." Dr. Eric Margolis, M.D.  is a Board-Ce

    4/25/24 8:45:00 AM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology